Confluence Life Sciences - Ownership and Business Overview

Life ScienceCompany

Confluence Life Sciences Ownership

Who owns Confluence Life Sciences?

Confluence Life Sciences is owned by Aclaris Therapeutics. It was acquired on August 8, 2017.

Confluence Life Sciences Business Overview

Where is Confluence Life Sciences headquartered?

Confluence Life Sciences is headquartered in Saint Louis, Missouri.

What sector is Confluence Life Sciences in?

Confluence Life Sciences is a life science company.

When was Confluence Life Sciences founded?

Confluence Life Sciences was founded in 2010.

Life Science M&A Summary in 2017

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2017. The largest life science acquisition in 2017 was Actelion - which was acquired by Johnson & Johnson for $30.0B.

Join Mergr to view all 249 acquisitions of life science companies in 2017, including 23 acquisitions by private equity firms, and 226 by strategics.

Confluence Life Sciences, Inc.

4320 Forest Park Avenue, Suite 303,
Saint Louis, Missouri 63108
United States,
(314) 932-4032
www.confluencelifesciences.com

Confluence Life Sciences, Inc. is a privately held biotechnology company focused on the discovery and development of kinase inhibitors to treat inflammatory and immunological disorders and cancer. Confluence Life Sciences was founded in 2010 and is based in Saint Louis, Missouri.


 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.